Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia A Without Inhibitors”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Large-scale testing (Phase 3)Looking for participantsNCT07545395
What this trial is testing

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Who this might be right for
Hemophilia A or B
Suzhou Alphamab Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Not applicableStudy completedNCT04165135
What this trial is testing

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Who this might be right for
Severe Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A
Hoffmann-La Roche 103
Post-approval studies (Phase 4)UnknownNCT03136003
What this trial is testing

DDAVP vs. Exercise in Patients With Mild Hemophilia A

Who this might be right for
Mild Haemophilia A Without Inhibitor
The Hospital for Sick Children 30
Not applicableStudy completedNCT03596814
What this trial is testing

MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II

Who this might be right for
Hemophilia
Nantes University Hospital 2,072
Large-scale testing (Phase 3)Study completedNCT05053139
What this trial is testing

A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

Who this might be right for
Haemophilia AHaemophilia A With Inhibitors
Novo Nordisk A/S 281
Large-scale testing (Phase 3)Study completedNCT03938792
What this trial is testing

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 188
Post-approval studies (Phase 4)Active Not RecruitingNCT05181618
What this trial is testing

Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Who this might be right for
Severe Hemophilia AModerate Hemophilia A
Hoffmann-La Roche 136
Testing effectiveness (Phase 2)Ended earlyNCT04541628
What this trial is testing

Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A

Who this might be right for
Hemophilia A
Eli Lilly and Company 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Early research (Phase 1)Study completedNCT04072237
What this trial is testing

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Who this might be right for
Hemophilia AHemophilia BHemophilia A With Inhibitor+3 more
Catalyst Biosciences 11
Large-scale testing (Phase 3)Study completedNCT04158648
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Who this might be right for
Mild Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHemophilia A
Hoffmann-La Roche 73
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04082429
What this trial is testing

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

Who this might be right for
Haemophilia A Without InhibitorsHaemophilia B Without Inhibitors
Novo Nordisk A/S 156
Testing effectiveness (Phase 2)Ended earlyNCT03597022
What this trial is testing

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Who this might be right for
Hemophilia A and B
Bayer 24
Large-scale testing (Phase 3)Active Not RecruitingNCT04431726
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors

Who this might be right for
Severe Hemophilia A
Hoffmann-La Roche 55
Not applicableNot Yet RecruitingNCT07653139
What this trial is testing

Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany

Who this might be right for
Haemophilia A
Novo Nordisk A/S 150
Not applicableLooking for participantsNCT05802836
What this trial is testing

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Who this might be right for
Severe Hemophilia ASevere Hemophilia A With InhibitorSevere Hemophilia A Without Inhibitor
Christoph Königs 100
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Post-approval studies (Phase 4)Looking for participantsNCT06145373
What this trial is testing

Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab

Who this might be right for
Hemophilia A
Sanofi 20
Next Page